Pharmaceutical Executive
Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs
June 17 · 3 min · 3.5 MB
0:00-3:34
Streams straight from the publisher. podnod never proxies or re-hosts episode audio.
In today's Pharmaceutical Executive Daily, FDA staff release briefing documents flagging evidence gaps in Moderna's mRNA flu vaccine, a pharma roundup covers Merck's $510 million collaboration with Protillion Biosciences and Jazz Pharmaceuticals' multi-program antibody discovery deal with AbCellera, and Jack McFeely argues that behavioral and engagement insights are the missing ingredient in patient support programs that struggle to sustain long-term persistence.
No links were found in this episode’s notes.